Literature DB >> 22228565

Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality.

Huann-Sheng Chen1, Kenneth Portier, Kaushik Ghosh, Deepa Naishadham, Hyune-Ju Kim, Li Zhu, Linda W Pickle, Martin Krapcho, Steve Scoppa, Ahmedin Jemal, Eric J Feuer.   

Abstract

BACKGROUND: A study was undertaken to evaluate the temporal projection methods that are applied by the American Cancer Society to predict 4-year-ahead projections.
METHODS: Cancer mortality data recorded in each year from 1969 through 2007 for the United States overall and for each state from the National Center for Health Statistics was obtained. Based on the mortality data through 2000, 2001, 2002, and 2003, Projections were made 4 years ahead to estimate the expected number of cancer deaths in 2004, 2005, 2006, 2007, respectively, in the United States and in each state, using 5 projection methods. These predictive estimates were compared to the observed number of deaths that occurred for all cancers combined and 47 cancer sites at the national level, and 21 cancer sites at the state level.
RESULTS: Among the models that were compared, the joinpoint regression model with modified Bayesian information criterion selection produced estimates that are closest to the actual number of deaths. Overall, results show the 4-year-ahead projection has larger error than 3-year-ahead projection of death counts when the same method is used. However, 4-year-ahead projection from the new method performed better than the 3-year-ahead projection from the current state-space method.
CONCLUSIONS: The Joinpoint method with modified Bayesian information criterion model has the smallest error of all the models considered for 4-year-ahead projection of cancer deaths to the current year for the United States overall and for each state. This method will be used by the American Cancer Society to project the number of cancer deaths starting in 2012.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22228565      PMCID: PMC3277448          DOI: 10.1002/cncr.27404

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches.

Authors:  Bjørn Møller; Harald Fekjaer; Timo Hakulinen; Helgi Sigvaldason; Hans H Storm; Mats Talbäck; Tor Haldorsen
Journal:  Stat Med       Date:  2003-09-15       Impact factor: 2.373

3.  The estimation of age, period and cohort effects for vital rates.

Authors:  T R Holford
Journal:  Biometrics       Date:  1983-06       Impact factor: 2.571

4.  Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.

Authors:  Rebecca Siegel; Elizabeth Ward; Otis Brawley; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2011-06-17       Impact factor: 508.702

5.  A new method of predicting US and state-level cancer mortality counts for the current calendar year.

Authors:  Ram C Tiwari; Kaushik Ghosh; Ahmedin Jemal; Mark Hachey; Elizabeth Ward; Michael J Thun; Eric J Feuer
Journal:  CA Cancer J Clin       Date:  2004 Jan-Feb       Impact factor: 508.702

6.  Cancer mortality in the United Kingdom: projections to the year 2025.

Authors:  A H Olsen; D M Parkin; P Sasieni
Journal:  Br J Cancer       Date:  2008-10-14       Impact factor: 7.640

  6 in total
  7 in total

1.  Cancer statistics for Asian Americans, Native Hawaiians, and Pacific Islanders, 2016: Converging incidence in males and females.

Authors:  Lindsey A Torre; Ann M Goding Sauer; Moon S Chen; Marjorie Kagawa-Singer; Ahmedin Jemal; Rebecca L Siegel
Journal:  CA Cancer J Clin       Date:  2016-01-14       Impact factor: 508.702

2.  Magnetic resonance elastography of the pancreas: Measurement reproducibility and relationship with age.

Authors:  Arunark Kolipaka; Samuel Schroeder; Xiaokui Mo; Zarine Shah; Phil A Hart; Darwin L Conwell
Journal:  Magn Reson Imaging       Date:  2017-05-02       Impact factor: 2.546

3.  Malaria in the Americas: trends from 1959 to 2011.

Authors:  Keith H Carter; Prabhjot Singh; Oscar J Mujica; Rainier P Escalada; Maria Paz Ade; Luis Gerardo Castellanos; Marcos A Espinal
Journal:  Am J Trop Med Hyg       Date:  2014-12-29       Impact factor: 2.345

4.  Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia.

Authors:  Yuanfei Shi; Dandan Xu; Yi Xu; Huafei Shen; Yan Zhang; Xiujin Ye; Jie Jin; Dawei Cui; Wanzhuo Xie
Journal:  J Oncol       Date:  2022-08-30       Impact factor: 4.501

5.  Updated Methodology for Projecting U.S.- and State-Level Cancer Counts for the Current Calendar Year: Part I: Spatio-temporal Modeling for Cancer Incidence.

Authors:  Benmei Liu; Li Zhu; Rebecca L Siegel; Eric J Feuer; Joe Zou; Huann-Sheng Chen; Kimberly D Miller; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-06-22       Impact factor: 4.090

6.  Increasing incidence of anogenital warts with an urban-rural divide among males in Manitoba, Canada, 1990-2011.

Authors:  Laura H Thompson; Zoann Nugent; James F Blanchard; Carla Ens; Bo Nancy Yu
Journal:  BMC Public Health       Date:  2016-03-03       Impact factor: 3.295

7.  TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin.

Authors:  Hui Wang; Qian Wu; Ying Zhang; Hua-Nan Zhang; Yong-Bin Wang; Wei Wang
Journal:  Cell Mol Biol Lett       Date:  2017-11-02       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.